The Lyme disease controversy: Social and financial costs of misdiagnosis and mismanagement

Archives of Internal Medicine

Volumn 156, Issue 14, 1996, Pages 1493-1500

  Sigal, Leonard H ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL HEMISUCCINATE; DOXYCYCLINE HYCLATE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; TETRACYCLINE;

ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HEALTH CARE COST; HUMAN; LYME DISEASE; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

COST OF ILLNESS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; HEALTH EXPENDITURES; HUMANS; LYME DISEASE; NEW JERSEY;

EID: 0030035699     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.14.1493     Document Type: Review

References (30)

1. Sigal LM, ed. Proceedings of The National Clinical Conference on Lyme Disease, New York, NY, December 1994. Am J Med. 1995;98(suppl):1-91.
2. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977;20:7-17.
3. Steere AC. Lyme disease. N Engl J Med. 1989; 321:586-596.
4. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308:733-740.
5. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 1983;308:740-742.
6. Golightly MG, Viciana AL. ELISA and immunoblots in the diagnosis of Lyme borreliosis: sensitivities and sources of false-positive results. In: Schutzer S, ed. Lyme Disease: Molecular and Immunologic Approaches, Current Communications in Cell and Molecular Biology 6. Plainview, NY: Cold Spring Harbor Laboratory Press; 1992:283-298.
7. Sigal LH. Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms. Semin Arthritis Rheum. 1989; 18: 151-167.
8. Szczepanski A, Benach JL. Lyme borreliosis: host response to Borrelia burgdorferi. Microbiol Rev. 1991;55:21-34.
9. Sigal LH. Immunopathogenic mechanisms in Lyme borreliosis. Clin Dermatol. 1993;11:415-422.
10. Sigal LH. Current drug therapy recommendations for the treatment of Lyme disease. Drugs. 1992;43:683-699.
11. Rahn DW, Malawista SE. Lyme disease: recommendations for diagnosis and treatment Ann Intern Med. 1991;114:472-481.
12. Sigal LH. Persisting complaints of Lyme disease: a conceptual review. Am J Med. 1994;96: 365-374.
13. Pachner AR. Borrelia burgdorferi in the nervous system: the new 'great imitator.' Ann N Y Acad Sd. 1988;539:56-64.
14. Finkel MJ, Halperin JJ. Nervous system Lyme borreliosis revisited. Arch Neural. 1992;49:102-107.
15. Sigal LH, Academy of Medicine of New Jersey Lyme Disease Task Force. Lyme Disease in New Jersey: A Practical Guide for New Jersey Clinicians. Lawrenceville, NJ: Academy of Medicine of New Jersey; 1993.
16. Sigal LH. Summary of the first one hundred patients seen at a Lyme disease referral center. Am J Med. 1990;88:577-581.
17. Hsu V, Patella SJ, Sigal LH. 'Chronic Lyme disease' as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum. 1993;36:1493-1500.
18. Sigal LH, Patella SJ. Lyme arthritis as the incorrect diagnosis in fibromyalgia in children and adolescents. Pediatrics. 1992;90:523-528.
19. Dinerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann Intern Med. 1992; 117:281-285.
20. Lightfoot RW Jr, Luft BJ, Rahn DW, et al. Treatment of 'possible Lyme disease': a practical policy position of the American College of Rheumatology and the Infectious Disease Society of America based on cost-benefit analysis. Ann Intern Med. 1993;119:503-509.
21. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA. 1993; 269:1812-1816.
22. Sigal LH. The role of the Borrelia burgdorferi polymerase chain reaction assay in the diagnosis of Lyme disease. Ann Intern Med. 1994;120:520-521. Editorial.
23. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993;167:392-400.
24. Genese C, Finelli L, Parkin W, Spitalny KC. Ceftriaxone-associated biliary complications of treatment of suspected disseminated Lyme disease: New Jersey, 1990-1992. MMWR Morbid Mortal Wkly Rep. 1993;42:39-42.
25. Subcommittee on Investigations and Oversight, Committee on Science, Space, and Technology, US House of Representatives (July 27, 1993) (testimony of S. Robert Lichter, PhD).
26. Barinaga M. Furor at Lyme disease conference. Science. 1992;256:1384-1385.
27. Patella S, Sigal LH, Taragin MI. Beliefs about Lyme disease (LD) in New Jersey: comparison of endemic and nonendemic areas. Arthritis Rheum. 1990;33(suppl):201.
28. Schwartz BS, Goldstein MD, Ribeiro JMC, Schulze TL, Shahied SI. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA. 1989;262:3431-3434.
29. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science. 1993; 260:1610-1616.
30. Aronowitz RA. Lyme disease: the social construction of a new disease and Its social consequences. Milbank Q. 1991;69:79-112.